Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma

Article information

Endocrinol Metab. 2022;37(1):180-180
Publication date (electronic) : 2022 February 28
doi : https://doi.org/10.3803/EnM.2022.103
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Corresponding author: Won Bae Kim. Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea, Tel: +82-2-3010-3913, Fax: +82-2-3010-6962, E-mail: kimwb@amc.seoul.kr

Endocrinol Metab 2021;36:717-724

https://doi.org/10.3803/EnM.2021.1042

This corrects the article “Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma” in Volume 36 on page 717.

There was an error in our recently published article in the Acknowledgments section, which should be revised as follows.

ACKNOWLEDGMENTS

This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HC19C0215).

We would like to apologize for any inconvenience or misunderstanding.

Article information Continued